AsortinoBeta
Gilead Sciences, Inc. logo

GILDGilead Sciences, Inc.

NASDAQStockHealthcareDrug Manufacturers - General🇺🇸 United StatesISIN US3755581036gilead.com
$151.000.15%
NASDAQ · at close Sep 4, 2026
Tokenized by
Reality logoBacked Finance logoDinari Inc. logo
3 issuersOn
Arbitrum One logoSolana logoEthereum logoXLayer logo
14 chains

Chart data are delayed by 15 minutes.

1D0.15%
1M+11.65%
3M+16.89%
1Y+33.90%
3Y+97.00%
5Y+109.84%

Main metrics

$187.23B
$656.1<0.01% of mkt cap
17.87
-$2.66
2.15%
6.2M
0.35
$108.4652-week range$157.29

About GILD

Gilead Sciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing medicines for serious diseases with unmet medical needs. Gilead Sciences specializes in therapeutic areas including HIV, viral hepatitis, oncology, inflammation, respiratory conditions, and cardiovascular disease. Its current portfolio includes prescription medicines and specialty treatments used in hospitals, clinics, and long-term care settings, supporting patients across global markets. The company also maintains an active pipeline in virology, oncology, and inflammation, reinforcing its role as a major provider of branded therapies in modern healthcare. Headquartered in Foster City, California, Gilead Sciences serves physicians, healthcare systems, and patients through a diversified product portfolio centered on infectious disease and specialty care.

Similar products

AbbVie Inc. logo
ABBVNYSE
$256.461.44%
AbbVie Inc.
Ondo Finance logoBacked Finance logoReality logo
4 issuers · 15 chains
Amgen Inc. logo
AMGNNASDAQ
$437.231.55%
Amgen Inc.
Ondo Finance logoBacked Finance logoReality logo
4 issuers · 14 chains
Biogen Inc. logo
BIIBNASDAQ
$220.831.64%
Biogen Inc.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 13 chains
Bristol-Myers Squibb Company logo
BMYNYSE
$66.821.87%
Bristol-Myers Squibb Company
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 14 chains